- Title
- Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis
- Creators
- Yong-Man Kim - Asan Medical CenterShin Nishio - Kurume UniversitySe Ik Kim - Seoul National UniversityKosei Hasegawa - Saitama Medical UniversityCoraline Dubot - Institut CurieM. Valeria Cáceres - Instituto de Oncología Ángel H. Roffo, Buenos Aires, ArgentinaKrishnansu S. Tewari - University of California, IrvineDomenica Lorusso - Humanitas UniversityJeong-Won Lee - Sungkyunkwan UniversityWen-Shiung Liou - Kaohsiung Veterans General HospitalKan Li - MerckCumhur Tekin - MerckNicoletta Colombo - European Institute of OncologyBradley J. Monk - Florida Cancer Specialists & Research Institute
- Publication Details
- Journal of gynecologic oncology, Vol.36
- Identifiers
- 991006167219902656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis
Journal of gynecologic oncology, Vol.36
2025
Metrics
1 Record Views